EUR 2.85
(-2.9%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -39.31 Million CAD | 45.22% |
2022 | -71.75 Million CAD | -100.9% |
2021 | -35.71 Million CAD | -462.12% |
2020 | -6.35 Million CAD | 75.68% |
2019 | -26.12 Million CAD | -476.41% |
2018 | -4.53 Million CAD | -1629.63% |
2017 | 296.31 Thousand CAD | -75.63% |
2016 | 1.21 Million CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | 717 Thousand CAD | 2968.0% |
2024 Q2 | -25 Thousand CAD | 92.65% |
2024 Q1 | -340 Thousand CAD | 98.87% |
2023 Q3 | -3.57 Million CAD | -131.48% |
2023 Q2 | -1.54 Million CAD | 60.85% |
2023 Q1 | -3.94 Million CAD | 92.54% |
2023 FY | -39.31 Million CAD | 45.22% |
2023 Q4 | -30.16 Million CAD | -743.96% |
2022 Q3 | -2.33 Million CAD | 71.93% |
2022 Q1 | -7.83 Million CAD | -60.52% |
2022 Q4 | -52.88 Million CAD | -2168.94% |
2022 FY | -71.75 Million CAD | -100.9% |
2022 Q2 | -8.3 Million CAD | -6.07% |
2021 Q1 | -16.86 Million CAD | -873.96% |
2021 Q3 | -1.81 Million CAD | 85.25% |
2021 Q4 | -4.87 Million CAD | -168.17% |
2021 Q2 | -12.33 Million CAD | 26.9% |
2021 FY | -35.71 Million CAD | -462.12% |
2020 FY | -6.35 Million CAD | 75.68% |
2020 Q2 | -5.04 Million CAD | -31.27% |
2020 Q4 | -1.73 Million CAD | -140.58% |
2020 Q1 | -3.84 Million CAD | 74.98% |
2020 Q3 | 4.26 Million CAD | 184.58% |
2019 Q3 | -3.69 Million CAD | -11.36% |
2019 FY | -26.12 Million CAD | -476.41% |
2019 Q4 | -15.36 Million CAD | -315.69% |
2019 Q2 | -3.31 Million CAD | 13.15% |
2019 Q1 | -3.82 Million CAD | 0.88% |
2018 Q3 | -605 Thousand CAD | -52.78% |
2018 Q2 | -396 Thousand CAD | -221.66% |
2018 FY | -4.53 Million CAD | -1629.63% |
2018 Q4 | -3.85 Million CAD | -537.28% |
2018 Q1 | 325.49 Thousand CAD | 218.19% |
2017 Q3 | 571.35 Thousand CAD | 0.0% |
2017 Q4 | -275.41 Thousand CAD | -148.2% |
2017 FY | 296.31 Thousand CAD | -75.63% |
2016 FY | 1.21 Million CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Newron Pharmaceuticals S.p.A. | -16.22 Million EUR | -142.295% |
Redcare Pharmacy NV | -12.04 Million EUR | -226.468% |